BCAL Diagnostics opens for business in the US

Medical screening and diagnostic company BCAL Diagnostics has announced the establishment of a US subsidiary BCAL Diagnostics, Inc. to speed the development of the company’s non invasive tests for breast cancer.

The company has purchased equipment from its development partner Precion Inc. required for the functioning of a US laboratory.

It has leased offices and a BCAL US research laboratory will commence operations 2 September 2024.

BCAL has is commercialising non-invasive diagnostic technologies designed to complement existing imaging technologies such as the mammogram and is developing a monitoring and screening tool accessible to all women.

Precion is undergoing a restructure and the company’s former CTO Dr. Klaus-Peter Adam will join BCAL US as full-time Director of US Research and Product Development and will oversee BCAL US operations.

BCAL CEO Shane Ryan said: “This is a wonderful opportunity for BCAL to establish its US presence, which is essential to our global market entry.

“Shareholders will recall from BCAL’s 2 August 2023 announcement the key role that Dr. Adam played in the 2023 clinical study, and we are extremely fortunate to have gained the services of Dr. Adam on a full-time dedicated basis.”

According to the company its US strategy is quickly building momentum.

“Dr. Adam is a highly credentialled scientist, specialising in the area of metabolomics and lipidomics who will bring much needed expertise to our growing US team and enhance our global research team.

“The US programme offers BCAL an opportunity to accelerate and validate new products on US patient centric data and gain an in-county understanding of the US diagnostics market.

“Collaboration with US physicians is progressing at the first partner two sites, Michigan and Chicago.”

The specific financial terms on which BCAL has been able to establish its US operations are commercially confidential, though the company recently completed a $10.5 million capital raising.

Picture: BCAL Diagnostics